Inborn mitochondrial metabolism disorder
MONDO:0004069Diseases caused by abnormal function of the mitochondria. They may be caused by mutations, acquired or inherited, in mitochondrial dna or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
Also known as: mitochondrial disease, mitochondrial genetic disorders, mitochondrial metabolism disease
129 clinical trials for this condition and its sub-types, 59 tagged with Inborn mitochondrial metabolism disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Inborn mitochondrial metabolism disorder
-
Mitochondrial oxidative phosphorylation disorder 3 trials · 58 incl. sub-types
48 sub-types
- Leber hereditary optic neuropathy 18 trials Sub-types →
- Mitochondrial DNA depletion syndrome 3 trials · 11 incl. sub-types Sub-types →
- Leigh syndrome 9 trials Sub-types →
- Kearns-Sayre syndrome 5 trials
- Maternally-inherited diabetes and deafness 5 trials
- Mitochondrial respiratory chain complex deficiency 4 trials · 5 incl. sub-types Sub-types →
- Deafness, aminoglycoside-induced 4 trials
- NARP syndrome 3 trials
- Autosomal dominant optic atrophy, classic form 3 trials
- Coenzyme Q10 deficiency 3 trials Sub-types →
- Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome 3 trials
- Myopathy, lactic acidosis, and sideroblastic anemia 3 trials Sub-types →
- Leber plus disease 1 trial · 2 incl. sub-types Sub-types →
- Ataxia neuropathy spectrum 2 trials Sub-types →
- Pontocerebellar hypoplasia type 6 2 trials
- Hereditary spastic paraplegia 7 1 trial
- Charcot-Marie-Tooth disease recessive intermediate D 0 trials
- Charcot-Marie-Tooth disease type 4K 0 trials
- FASTKD2-related infantile mitochondrial encephalomyopathy 0 trials
- Perrault syndrome 0 trials Sub-types →
- Zellweger-like syndrome without peroxisomal anomalies 0 trials
- Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 0 trials
- Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy 0 trials Sub-types →
- Autosomal dominant mitochondrial myopathy with exercise intolerance 0 trials
- Autosomal dominant optic atrophy and peripheral neuropathy 0 trials
- Autosomal recessive optic atrophy, OPA7 type 0 trials
- Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0 trials
- Chronic diarrhea with villous atrophy 0 trials
- Combined oxidative phosphorylation deficiency 0 trials Sub-types →
- Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0 trials
- Encephalopathy due to mitochondrial and peroxisomal fission defect 0 trials Sub-types →
- Fatal infantile encephalocardiomyopathy 0 trials Sub-types →
- Hereditary spastic paraplegia 55 0 trials
- Hereditary spastic paraplegia 77 0 trials
- Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome 0 trials
- Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation 0 trials
- Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 0 trials
- Maternally-inherited mitochondrial dystonia 0 trials
- Maternally-inherited progressive external ophthalmoplegia 0 trials
- Mitochondrial DNA maintenance syndrome 0 trials
- Mitochondrial non-syndromic sensorineural hearing loss 0 trials Sub-types →
- Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy 0 trials
- Optic atrophy 3 0 trials
- Periodic paralysis with later-onset distal motor neuropathy 0 trials
- Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency 0 trials
- Spastic ataxia 3 0 trials
- Spastic ataxia 4 0 trials
- Spinocerebellar ataxia type 28 0 trials
-
Inborn mitochondrial myopathy 18 trials · 45 incl. sub-types
24 sub-types
- Mitochondrial encephalomyopathy 3 trials · 15 incl. sub-types Sub-types →
- Progressive external ophthalmoplegia 4 trials · 8 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mitochondrial neurogastrointestinal encephalomyopathy 4 trials Sub-types →
- Mitochondrial trifunctional protein deficiency 3 trials Sub-types →
- Myopathy, lactic acidosis, and sideroblastic anemia 3 trials Sub-types →
- Adenosine monophosphate deaminase deficiency 1 trial
- Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis 1 trial Sub-types →
- COX deficiency, benign infantile mitochondrial myopathy 0 trials
- X-linked recessive mitochondrial myopathy 0 trials
- Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy 0 trials Sub-types →
- Autosomal dominant mitochondrial myopathy with exercise intolerance 0 trials
- Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0 trials
- Fatal infantile encephalocardiomyopathy 0 trials Sub-types →
- Lethal infantile mitochondrial myopathy 0 trials
- Maternally-inherited progressive external ophthalmoplegia 0 trials
- Mitochondrial complex I deficiency, nuclear type 1 0 trials
- Mitochondrial complex II deficiency, nuclear type 0 trials Sub-types →
- Mitochondrial myopathy with a defect in mitochondrial-protein transport 0 trials
- Mitochondrial myopathy with diabetes 0 trials
- Mitochondrial myopathy with reversible cytochrome C oxidase deficiency 0 trials
- Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy 0 trials
- Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome 0 trials
- Mitochondrial myopathy-lactic acidosis-deafness syndrome 0 trials
-
Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types
7 sub-types
- Pyruvate dehydrogenase E1-alpha deficiency 2 trials
- Pyruvate dehydrogenase E3 deficiency 1 trial
- Lipoic acid synthetase deficiency 0 trials
- Pyruvate dehydrogenase E1-beta deficiency 0 trials
- Pyruvate dehydrogenase E2 deficiency 0 trials
- Pyruvate dehydrogenase E3-binding protein deficiency 0 trials
- Pyruvate dehydrogenase phosphatase deficiency 0 trials
-
Histiocytoid cardiomyopathy 3 trials
1 sub-type
- Cardiac lipidosis, familial 0 trials
-
Fumaric aciduria 2 trials
-
1 sub-type
- Behr syndrome 0 trials
-
5 sub-types
- Glutaric acidemia IIa 0 trials
- Glutaric acidemia IIb 0 trials
- Glutaric acidemia IIc 0 trials
- Multiple acyl-CoA dehydrogenase deficiency, mild type 0 trials
- Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type 0 trials
-
Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types
6 sub-types
- Pyruvate dehydrogenase E3 deficiency 1 trial
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Fatal multiple mitochondrial dysfunctions syndrome 0 trials Sub-types →
- Lipoic acid synthetase deficiency 0 trials
- Lipoyl transferase 1 deficiency 0 trials
- Spasticity-ataxia-gait anomalies syndrome 0 trials
-
HSD10 mitochondrial disease 0 trials
3 sub-types
- HSD10 disease, atypical type 0 trials
- HSD10 disease, infantile type 0 trials
- HSD10 disease, neonatal type 0 trials
-
Hypotonia-cystinuria syndrome 0 trials
1 sub-type
-
2 sub-types
-
Oxoglutaricaciduria 0 trials
Most studied deeper sub-types
-
Can a common supplement shrink fatty liver in a rare diabetes?
Disease control Not yet recruitingThis trial tests whether taking coenzyme Q10 (CoQ10) for 12 weeks can reduce fat buildup in the liver of people with mitochondrial diabetes, a rare form of diabetes caused by mitochondrial dysfunction. Participants with the m.3243A>G mutation will take 300 mg of CoQ10 daily, and …
Sponsor: The 95th Hospital of Putian,Putian, Fujian, China • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new oral drug help tame leigh syndrome?
Disease control Not yet recruitingThis trial tests an experimental oral drug, TTI-0102, in people aged 5 to 55 with Leigh syndrome spectrum, a rare genetic disorder that damages the brain and nerves. The study aims to find the right dose and check safety over 12 weeks of twice-daily treatment. Participants will h…
Phase 2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare mitochondrial diseases that cause severe symptoms like strokes and vision loss. The trial is open-label (everyone gets the drug) and uses each person as their own control over…
Phase 1/2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Lifestyle makeover tested as MS symptom fighter
Disease control Not yet recruitingThis study tests whether a structured 12-week program focusing on nutrition, exercise, sleep, and stress management can improve fatigue, physical function, and quality of life in people with relapsing-remitting multiple sclerosis. Thirty participants will first be observed for 12…
Sponsor: New York University Abu Dhabi • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could your own stem cells fight this rare brain disorder?
Disease control Not yet recruitingThis study tests whether a person's own stem cells, processed and given by IV, can safely help with multiple system atrophy (MSA) — a rare, worsening brain disease that affects movement and automatic body functions like blood pressure. Fifty adults aged 35 to 65 will receive eith…
Phase 2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could vitamin B3 save sight in rare genetic blindness?
Disease control Not yet recruitingThis early study tests whether high-dose vitamin B3 (nicotinamide) can help preserve or improve vision in people with Leber's hereditary optic neuropathy (LHON), a rare genetic disease that causes sudden vision loss. Researchers will give 13 participants 2 grams of vitamin B3 dai…
Phase 1 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New DNA test could end years of uncertainty for mitochondrial disease patients
Diagnosis Not yet recruitingThis pilot study aims to develop a new digital PCR technique to more accurately diagnose mitochondrial diseases. Researchers will test the method on blood, urine, saliva, and muscle fiber samples from 4 patients. If validated, the technique could be faster and cheaper than curren…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Could a daily supplement recharge aging cells?
Prevention Not yet recruitingThis trial tests whether taking coenzyme Q10 (CoQ10) for 10 weeks can improve biological resilience in adults aged 65 and older who show early signs of frailty. Participants will be randomly assigned to receive either 200 mg of CoQ10 daily or a placebo. The study will measure cha…
Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Scientists probe cellular 'Power Plants' to unlock secrets of aging
Knowledge-focused Not yet recruitingThis study looks at how aging changes tiny parts of our cells called mitochondria, which produce energy. Researchers will take small skin samples and blood from 90 healthy adults aged 18-90 to measure inflammation and cell aging markers. The goal is to better understand why we ag…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to unravel Parkinson's protein mysteries
Knowledge-focused Not yet recruitingThis study looks at how abnormal proteins, like alpha-synuclein and tau, build up and affect brain function in people with Parkinson's disease. Researchers will use brain scans, blood tests, and skin biopsies to track these changes. The goal is to find better ways to diagnose and…
Sponsor: University of Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC